Projects per year
Fingerprint Dive into the research topics where Jeffrey Laskin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Macrophages
Medicine & Life Sciences
Lung
Medicine & Life Sciences
Nitric Oxide
Medicine & Life Sciences
Mustard Gas
Medicine & Life Sciences
Lung Injury
Medicine & Life Sciences
Ozone
Medicine & Life Sciences
Irritants
Medicine & Life Sciences
Keratinocytes
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2006 2021
Rutgers University Counteract Center Of Excellence
National Institutes of Health (NIH)
9/15/06 → 6/30/21
Project: Research project
Mustard Plant
Irritants
Research
Pharmaceutical Preparations
Drug Discovery
intellectual property
resources
research and development
research project
candidacy
Education And Training Program
National Institutes of Health (NIH)
7/1/14 → 9/21/16
Project: Research project
training program
threat
school
grant
education
Developing Drugs To Mitigate Parathion Intoxication
National Institutes of Health (NIH)
9/16/13 → 8/31/18
Project: Research project
Parathion
Paraoxon
Pharmaceutical Preparations
Organophosphates
Cytochrome P-450 Enzyme System
Umdnj/Rutgers University Counteract Research Center Of Excellence
National Institutes of Health (NIH)
9/15/06 → 9/21/16
Project: Research project
Irritants
Research
Pharmaceutical Preparations
Pharmaceutical Chemistry
Pharmacology
Research Output 1976 2019
Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis
Szilagyi, J. T., Composto-Wahler, G. M., Joseph, L. B., Wang, B., Rosen, T., Laskin, J. & Aleksunes, L., Mar 1 2019, In : Pharmacological Research. 141, p. 331-342 12 p.Research output: Contribution to journal › Article
Cannabinoid Receptor CB2
Trophoblasts
Down-Regulation
Cyclic AMP Response Element-Binding Protein
Messenger RNA
Hydroxyl Radicals in E-Cigarette Vapor and E-Vapor Oxidative Potentials under Different Vaping Patterns
Son, Y., Mishin, V., Laskin, J., Mainelis, G., Wackowski, O., Delnevo, C., Schwander, S., Khlystov, A., Samburova, V. & Meng, Q., Jun 17 2019, In : Chemical Research in Toxicology. 32, 6, p. 1087-1095 9 p.Research output: Contribution to journal › Article
Tobacco Products
Hydroxyl Radical
Vapors
Vegetables
Glycerol
Phototoxicity of 7-oxycoumarins with keratinocytes in culture
Guillon, C., Jan, Y. H., Heck, D. E., Mariano, T. M., Rapp, R. D., Jetter, M., Kardos, K., Whittemore, M., Akyea, E., Jabin, I., Laskin, J. & Heindel, N. D., Aug 1 2019, In : Bioorganic Chemistry. 89, 103014.Research output: Contribution to journal › Article
Phototoxic Dermatitis
Keratinocytes
Coumarins
Light
Growth
1
Citation
(Scopus)
Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone
Szilagyi, J. T., Gorczyca, L., Brinker, A., Buckley, B., Laskin, J. & Aleksunes, L., Apr 1 2019, In : Toxicological Sciences. 168, 2, p. 394-404 11 p.Research output: Contribution to journal › Article
Zearalenone
Mycotoxins
Breast Neoplasms
Placenta
Proteins
Role of Macrophages in Acute Lung Injury and Chronic Fibrosis Induced by Pulmonary Toxicants
Laskin, D., Malaviya, R. & Laskin, J., Apr 1 2019, In : Toxicological Sciences. 168, 2, p. 287-301 15 p.Research output: Contribution to journal › Review article
Pulmonary Fibrosis
Acute Lung Injury
Macrophages
Wounds and Injuries
Fibrosis
Press/Media
New Jersey Health Foundation Awards Excellence in Teaching, Research
Cheryl Dreyfus, Jeffrey Laskin, Ronald Ellis, Jane Ziegler & Debra Laskin
6/5/17 → 6/6/17
70 items of Media coverage
Rutgers, The State University, Rowan University
Press/Media: Press / Media
New Jersey Health Foundation Awards Excellence in Teaching Research
Ronald Ellis, Debra Laskin, Cheryl Dreyfus, Jeffrey Laskin & Jane Ziegler
6/5/17
1 item of Media coverage
Rutgers, The State University, Rowan University
Press/Media: Press / Media
$19 million to develop drugs to treat victims of chemical weapons attacks
12/8/16
1 item of Media coverage
Press/Media: Press / Media
Rutgers Receives $19 Million to Develop Drugs to Treat Chemical Weapons Attacks
Marion Gordon, Debra Laskin, Donald Gerecke, Jeffrey Laskin & Patrick Sinko
12/1/16
4 items of Media coverage
Press/Media: Press / Media
US Patent Issued to Rutgers, The State University of New Jersey, LEHIGH UNIVERSITY on Aug. 23 for "Vanilloid fatty hydroxamates as therapeutic anti-inflammatory pharmaceuticals" (American, Indian Inventors)
Marion Gordon & Jeffrey Laskin
8/23/16
1 item of Media coverage
Press/Media: Press / Media